SCHEMBL31469002

SCHEMBL31469002

Cc1ncccc1-c1cccnc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.52
MKNK2 Q9HBH9 1/20 0.52
TDO2 P48775 1/20 0.50
VHL P40337 1/20 0.47
TDP1 Q9NUW8 2/20 0.44
HSP90AA1 P07900 2/20 0.44
TDP2 O95551 1/20 0.44
NSD2 O96028 1/20 0.44
ABL1 P00519 1/20 0.44
PLCG1 P19174 1/20 0.44
CES1 P23141 1/20 0.44
PAX8 Q06710 1/20 0.44
RIN1 Q13671 1/20 0.44
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
NOS2 P35228 1/20 0.44
MEN1 O00255 1/20 0.44
THRB P10828 1/20 0.44
BLM P54132 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3421959 1.00 MKNK1 (0.52) MKNK1MKNK2TDO2VHLTDP1
SCHEMBL9963986 0.88 NOS3 (0.46) MKNK1MKNK2TDO2VHLTDP1
SCHEMBL27941864 0.87 MKNK1 (0.56) MKNK1MKNK2TDO2VHLTDP1
SCHEMBL23731203 0.86 NOS3 (0.56) MKNK1MKNK2TDO2VHLNOS3
SCHEMBL28231982 0.86 KDM4E (0.50) MKNK1MKNK2TDO2VHLGAA
SCHEMBL15730138 0.84 MKNK1 (0.50) MKNK1MKNK2TDO2VHLHTT
SCHEMBL18174898 0.84 VHL (0.43) MKNK1MKNK2TDO2VHLPDE2A
SCHEMBL15731251 0.84 PDE2A (0.48) MKNK1MKNK2TDO2VHLKMT2A
SCHEMBL4446669 0.84 MKNK1 (0.46) MKNK1MKNK2TDO2VHLMEN1
SCHEMBL30563610 0.83 MKNK1 (0.58) MKNK1MKNK2TDO2VHLHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025029860-A1 DRUG CONJUGATES AND METHODS OF PREPARING AND USING THE SAME ADCENTRX THERAPEUTICS INC. (US) 2025-02-06 WO disclosed